Sort
64,565 grants matching “drug discovery”
ETIOLOGY OF SUBSTANCE USE IN AUSTRALIA /USA
$892,518University Of Washington · R01 · FY2002 · DA
Novel Therapies for BioFilm-Related Infections
$892,465Microbiotix, Inc · R44 · FY2005 · AI
Integrative genomic analysis of the human response to glucocorticoids
$892,450Luis Franco · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
$892,417Subramaniam Ananthan · Southern Research Institute · R01 · FY2018 · DA
DCTD Functional Genomics
$892,388David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Cartilage Molecular Genetics
$892,329David J Hall · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)
$892,154Amber Dahlin · Brigham And Women'S Hospital · R01 · FY2021 · HL
SBIR Phase II: High multiplex visual mapping of heterogeneity in FFPE biospecimen
$892,086Dmitry N Derkach · Biosyntagma, Llc · · FY2018 · TIP
Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
$892,054Thomas Dick · Hackensack University Medical Center · R01 · FY2024 · AI
Engineering Multifunctional Nanoparticles
$892,000Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2006 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$891,685James E. Heubi · University Of Cincinnati · UL1 · FY2011 · RR
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
$891,540Sung Hwan Cho · Nanocellect Biomedical, Inc. · R44 · FY2022 · GM
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$891,375Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)
$891,259Amber Dahlin · Brigham And Women'S Hospital · R01 · FY2023 · HL
Discovery of genetic interactions in cancer
$891,204Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Isochoric Pressure Based Preservation of Cells, Tissues and Organs
$890,768Michael John Taylor · Sylvatica Biotech, Inc. · R44 · FY2021 · AI
Open Drug Discovery Center for Alzheimer's Disease
$890,584Allan I Levey · Emory University · U54 · FY2020 · AG
Exploration, conservation, & development of marine biodiversity in Fiji
$890,507Mark E Hay · Georgia Institute Of Technology · U01 · FY2009 · TW
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
$890,494John M Littleton · Naprogenix, Inc · R44 · FY2020 · AA
Molecular strategies for early detection and targeting of cancer
$890,314Tannishtha Reya · University Of California, San Diego · R35 · FY2020 · CA
The integrated stress response in cognitive disorders
$890,226Paul Pfaffinger · Baylor College Of Medicine · R01 · FY2022 · NS
AMP RA/SLE Leadership Center
$890,185Paul Joseph Utz · Stanford University · UM2 · FY2016 · AR
Integrative Omics to enhance therapeutics development for healthy aging
$890,118Nicholas Joseph Schork · Translational Genomics Research Inst · UH3 · FY2021 · AG
DISCOVERY OF NEW ANTICANCER AGENTS FROM NATURAL PRODUCTS
$889,966Wayne State University · U19 · FY2000 · CA
A High Throughput Biofilm Assay System
$889,579Cristian Ionescu-Zanetti · Fluxion Biosciences, Inc. · R44 · FY2010 · GM